The function of astrocytes and their role in neurological diseases

Abstract

Astrocytes have countless links with neurons. Previously, astrocytes were only considered a scaffold of neurons; in fact, astrocytes perform a variety of functions, including providing support for neuronal structures and energy metabolism, offering isolation and protection and influencing the formation, function and elimination of synapses. Because of these functions, astrocytes play an critical role in central nervous system (CNS) diseases. The regulation of the secretiory factors, receptors, channels and pathways of astrocytes can effectively inhibit the occurrence and development of CNS diseases, such as neuromyelitis optica (NMO), multiple sclerosis, Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease. The expression of aquaporin 4 in AS is directly related to NMO and indirectly involved in the clearance of Aβ and tau proteins in AD. Connexin 43 has a bidirectional effect on glutamate diffusion at different stages of stroke. Interestingly, astrocytes reduce the occurrence of PD through multiple effects such as secretion of related factors, mitochondrial autophagy and aquaporin 4. Therefore, this review is focused on the structure and function of astrocytes and the correlation between astrocytes and CNS diseases and drug treatment to explore the new functions of astrocytes with the astrocytes as the target. This, in turn, would provide a reference for the development of new drugs to protect neurons and promote the recovery of nerve function.

Clathrin mediated endocytosis in Alzheimer’s disease: cell type specific involvement in amyloid beta pathology

“…Astrocytes are closely tied to the clearance of dying neurons and take up large amounts of neuronal Aβ 1-42 and debris ( Yuan et al, 2023 ; Mun et al, 2024 ). However, astrocytes can become overburdened with Aβ, resulting in impaired phagocytosis of diseased synapses and potentially contributing to the increased amount of dystrophic neurites seen in early stages of AD ( Sanchez-Mico et al, 2021 ).…”

Dihydropashanone Isolated from Lindera erythrocarpa, a Potential Natural Product for the Treatment of Neurodegenerative Diseases

“…Recently, increasing attention has been paid to the identification of novel natural agents that can control microglial activation to treat or prevent neuroinflammation [ 10 , 11 , 12 ]. Functional neuronal cell loss is a significant cause of neurodegenerative illnesses, and glutamate is an excitatory neurotransmitter that plays a key role in synaptic plasticity in the brain [ 13 ]. However, glutamate imbalance (excessively high levels) can damage cellular components, including mitochondria, and promote ROS production, leading to neurotoxicity and neuronal cell damage [ 14 ].…”